ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1137

Multiway Transcriptomic Analysis of Monocyte-Derived Dendritic Cells Discriminates Effects of Disease and of HLA-B27 in Spondyloarthritis

Emmanuel Chaplais1, Alice Talpin2, Félicie Costantino1, Clémence Desjardin1, Nelly Bonilla2, Ariane Leboime3, Roula Said Nahal4, Franck Letourneur2, Jacques Sébastien2, Gilles Chiocchia5, Maxime Breban1 and Henri-Jean Garchon1, 1INSERM U987, Faculté des Sciences de la Santé Simone Veil, Montigny-le-Bretonneux, France, 2INSERM U1016, Cochin Institute, Paris, France, 3Rheumatology Division, Ambroise-Paré Hospital AP-HP, Boulogne-Billancourt, France, 4Service de Rhumatologie, Hopital Ambroise Pare, Boulogne-Billancourt, France, 5Versailles Saint Quentin en Yvelines University, INSERM U987, UFR des Sciences de la Santé, Montigny-le-Bretonneux, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Collagen, Dendritic cells, spondylarthritis and transcriptional regulation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics II

Session Type: Abstract Submissions (ACR)

Background/Purpose

Spondyloarthritis (SpA) etiology is largely multifactorial with a genetic component dominated by the long-known strong association with the HLA-B27 allele. This allele, however, is not sufficient for the disease to occur. Whereas dendritic cells are believed to play a key role in SpA pathogenesis, the precise mechanisms underlying disease development and particularly the role of HLA-B27 remain poorly understood. To shed light on the genes involved, we carried out a transcriptome analysis of dendritic cells from patients and healthy controls, also accounting for HLA-B27.

Methods

Transcriptomic profiles of monocyte-derived dendritic cells (MD-DCs) were obtained from 23 HLA-B27+ SpA patients, and from 44 controls (23 HLA-B27+ and 21 HLA-B27-). MD-DCs were stimulated or not with endotoxin for 6 or 24 hrs. We used the Affymetrix Human Gene 1.0 ST platform. Analysis of differentially expressed (DE) genes was conducted with LIMMA considering both the disease and the HLA-B27 status (p-value < 5%), followed by quantitative gene set enrichment analyses (quSAGE) and functional pathway annotation.

Results

We performed three comparisons to identify DE genes related to HLA-B27 or SpA status, thus generating three lists: A, including 800 DE genes between HLA-B27+ SpA patients and HLA-B27- healthy controls; B, including 673 DE genes between HLA-B27+ controls and HLA-B27- controls; and C, including 466 DE genes between HLA-B27+ patients and HLA-B27+ controls. Subtracting A–B left 656 genes, of which 68 are in list C, thus yielding a robust list of genes affected by SpA and filtering out irrelevant genes affected by HLA-B27. The most significantly DE gene was procollagen C-endopeptidase enhancer 2 (PCOLCE2), which was overexpressed in patients compared to both HLA-B27- (Fold Change = 2.35, P = 9×10-4) and HLA-B27+ (FC = 3.57, P = 2.7×10-6) controls. This gene codes for an enhancer of bone morphogenic protein-1 (BMP1) that facilitates the cleavage of procollagen and apolipoproteins. QuSAGE and functional annotation revealed that DE genes and gene sets associated with SpA were mainly related to lipid biosynthesis, autophagy, and ribosomal units.

Conclusion

Our study identified a list of MD-DC genes and functions that differ between SpA and controls after controlling for HLA-B27 and involve major pathways, including lipid synthesis, autophagy and ribosomal function. The most striking DE gene, PCOLCE2 is known to interact physically with BMP1, an enzyme that is implicated in ossification and cartilage formation. BMP1 loss-of-function mutations can cause osteogenesis imperfecta. Thus, it is conceivable that a mechanism of gain-of-function of BMP1 signalling pathway could be implicated in the SpA pathogenic process.


Disclosure:

E. Chaplais,
None;

A. Talpin,
None;

F. Costantino,
None;

C. Desjardin,
None;

N. Bonilla,
None;

A. Leboime,
None;

R. Said Nahal,
None;

F. Letourneur,
None;

J. Sébastien,
None;

G. Chiocchia,
None;

M. Breban,
None;

H. J. Garchon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multiway-transcriptomic-analysis-of-monocyte-derived-dendritic-cells-discriminates-effects-of-disease-and-of-hla-b27-in-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology